GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aprogen Biologics Inc (XKRX:003060) » Definitions » Shiller PE Ratio

Aprogen Biologics (XKRX:003060) Shiller PE Ratio : (As of May. 18, 2024)


View and export this data going back to 1984. Start your Free Trial

What is Aprogen Biologics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Aprogen Biologics Shiller PE Ratio Historical Data

The historical data trend for Aprogen Biologics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprogen Biologics Shiller PE Ratio Chart

Aprogen Biologics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Aprogen Biologics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Aprogen Biologics's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Aprogen Biologics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aprogen Biologics's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aprogen Biologics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Aprogen Biologics's Shiller PE Ratio falls into.



Aprogen Biologics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Aprogen Biologics's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Aprogen Biologics's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1191.92/118.8477*118.8477
=-1,191.920

Current CPI (Dec. 2023) = 118.8477.

Aprogen Biologics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -104.981 99.253 -125.707
201406 -62.988 99.353 -75.347
201409 -104.981 99.608 -125.259
201412 -20.996 99.098 -25.180
201503 -10.498 99.720 -12.512
201506 230.957 100.050 274.350
201509 15.747 100.110 18.694
201512 55.367 100.220 65.658
201603 -0.787 100.560 -0.930
201606 -10.498 100.790 -12.379
201609 -47.241 101.460 -55.337
201612 -194.214 101.560 -227.273
201703 -131.226 102.850 -151.637
201706 -204.712 102.610 -237.107
201709 -619.386 103.490 -711.302
201712 -94.483 102.990 -109.031
201803 -115.479 104.100 -131.839
201806 89.234 104.130 101.846
201809 194.214 105.650 218.475
201812 -262.452 104.350 -298.915
201903 -246.704 104.490 -280.603
201906 96.703 104.880 109.582
201909 -69.074 105.200 -78.035
201912 -82.889 105.120 -93.714
202003 110.518 105.540 124.453
202006 125.466 104.870 142.189
202009 94.099 106.200 105.306
202012 -54.891 105.765 -61.681
202103 39.208 107.357 43.404
202106 31.366 107.579 34.652
202109 54.891 108.759 59.983
202112 31.366 109.676 33.989
202203 54.891 111.806 58.348
202206 62.733 114.083 65.353
202209 86.258 114.831 89.275
202212 39.208 115.200 40.449
202303 15.683 116.550 15.992
202306 -219.565 117.140 -222.766
202309 -54.891 119.111 -54.770
202312 -1,191.920 118.848 -1,191.920

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Aprogen Biologics  (XKRX:003060) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Aprogen Biologics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Aprogen Biologics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aprogen Biologics (XKRX:003060) Business Description

Traded in Other Exchanges
N/A
Address
545, Dunchon-daero, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR
Aprogen Biologics Inc is specialized in manufacturing and selling various pharmaceutical products including amino acid infusion agents and antibiotics.

Aprogen Biologics (XKRX:003060) Headlines

No Headlines